The Role of Fibroblasts in Dystrophic Epidermolysis Bullosa Pathogenesis and Current Treatment Approaches
Dystrophic epidermolysis bullosa (DEB) is a hereditary skin fragility disease characterized by the loss or dysfunction of collagen VII, predisposing patients to dermal–epidermal separation. This disease is highly associated with the development of progressive fibrosis of the skin and other organs an...
Saved in:
| Main Authors: | Alexander Nyström, Celine Pattaroni, Johannes S. Kern |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | JID Innovations |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667026725000074 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms
by: Alexander Nyström, et al.
Published: (2015-07-01) -
Pro‐inflammatory immunity supports fibrosis advancement in epidermolysis bullosa: intervention with Ang‐(1‐7)
by: Rocco Bernasconi, et al.
Published: (2021-08-01) -
A Novel COL7A1 Mutation in a Patient With Dystrophic Epidermolysis Bullosa. Successful Treatment With Upadacitinib
by: Lai S, et al.
Published: (2025-01-01) -
Systemic treatment of recessive dystrophic epidermolysis bullosa with mesenchymal stromal cells: a scoping review of the literature and conclusions for future clinical research
by: Elke Niebergall-Roth, et al.
Published: (2024-12-01) -
Cemiplimab‐Induced Colitis Causing Hypovolemic Shock: A Case Report and Literature Review
by: Saeed S. Graham, et al.
Published: (2025-06-01)